On May 6, 2025, JP Morgan analyst Rachel Vatnsdal updated her outlook on Twist Bioscience (TWST, Financial), maintaining the company's current rating while lowering the price target. The rating remains at "Underweight," consistent with the previous assessment.
The revised price target for TWST is set at $33.00 USD, down from the prior target of $40.00 USD. This adjustment represents a 17.5% decrease in expectations for the stock's performance. This move reflects JP Morgan's ongoing evaluation of the market conditions and the company's prospects.
Twist Bioscience (TWST, Financial) continues to attract attention from investors and analysts as they monitor developments in its business operations and financial metrics. The updated price target underscores the importance of staying informed on the latest analyst opinions and market trends for those tracking the performance of TWST.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 11 analysts, the average target price for Twist Bioscience Corp (TWST, Financial) is $51.47 with a high estimate of $62.00 and a low estimate of $44.00. The average target implies an upside of 43.25% from the current price of $35.93. More detailed estimate data can be found on the Twist Bioscience Corp (TWST) Forecast page.
Based on the consensus recommendation from 13 brokerage firms, Twist Bioscience Corp's (TWST, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) in one year is $59.61, suggesting a upside of 65.91% from the current price of $35.93. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Twist Bioscience Corp (TWST) Summary page.
